Tag: biosimilar regulatory approval
Manufacturing Challenges for Biosimilars: Why Copying Biologics Is Far Harder Than Generics
Biosimilars aren't simple copies of biologics-they're complex, living molecules made in cells. Manufacturing them requires matching tiny structural details like glycosylation, scaling up without losing quality, and navigating strict global regulations-all while keeping costs low.